Non-opioid dynorphin binding site on secretory vesicles of a pituitary- derived cell line

Brain Research

Volumn 791, Issue 1-2, 1998, Pages 99-107

  Yarygin, Konstantin N ^a   Zhang, Xi Hong ^a   Lee, Nancy M ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

ACTH; AtT 20 cell; Dynorphin; Non opioid binding site

Indexed keywords

CORTICOTROPIN; CORTICOTROPIN[1-39]; DYNORPHIN A; DYNORPHIN[1-13];

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BINDING SITE; CELL FRACTIONATION; CELL TRANSPORT; CONTROLLED STUDY; CORTICOTROPIN RELEASE; DISSOCIATION CONSTANT; HYPOPHYSIS CELL; MEMBRANE VESICLE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADRENOCORTICOTROPIC HORMONE; ANALGESICS, OPIOID; ANIMALS; CELL LINE; CYTOPLASMIC GRANULES; DYNORPHINS; ENERGY METABOLISM; MICE; PEPTIDE FRAGMENTS; PITUITARY GLAND; RECEPTORS, OPIOID; SUBCELLULAR FRACTIONS;

EID: 0032571763     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00084-5     Document Type: Article

References (31)

1. Aceto M.D., Dewey W.L., Chang J.K., Lee N.M. Dynorphin-1-13 substitutes for morphine in addicted Rhesus monkeys. Eur. J. Pharmacol. 83:1982;139-142.
2. Chen L., Gu Y., Huang L.-Y.M. The opioid peptide dynorphin directly blocks NMDA receptor channels in the rat. J. Physiol. 482.3:1995;575-581.
3. Codd E.E., Aloyo V.J., Walker R.F. A non-opioid pattern characterizes inhibition of growth hormone releasing peptide binding by dynorphin-related peptides. Neuropeptides. 15:1990;133-137.
4. Desarnaud F., Labbe O., Eggerickx D., Vassart G., Parmentier M. Molecular cloning, functional expression and pharmacological characterization of a mouse melanocortin receptor gene (MC3). Biochem. J. 299:1994;367-373.
5. Dumont M., Lemaire S. Interactions of dynorphin A and related peptides with cardiac ouabain binding sites. J. Mol. Cell. Cardiol. 28:1996;615-621.
6. Faden A.I. Dynorphin increases extracellular levels of excitatory amino acids in the brain through a non-opioid mechanism. J. Neurosci. 12:1992;425-429.
7. Fan L., McIntosh T.K. Cardiovascular effects of microinjection of dynorphin fragments into the nucleus of the solitary tract (NTS) are mediated by non-opioid mechanisms. Brain Res. 623:1993;110-116.
8. Friedman H.J., Jen M.F., Chang J.K., Lee N.M., Loh H.H. Dynorphin: a possible modulatory peptide on morphine or beta-endorphin analgesia in mouse. Eur. J. Pharmacol. 69:1981;357-360.
9. 1]DynorphinA-(2-17) has naloxone-insensitive antinociceptive effect in the writhing assay. J. Pharmacol. Exp. Ther. 273:1995;802-807.
10. Hunter J.C., Purbrick S., Boden P.R., Woodruff G.N. Dynorphin interaction with the NMDA receptor/channel complex: correlation with spinal cord injury. Regul. Pept. 1:1994;S89-S90. Suppl.
11. Jacobs L.S., Lorenson M.Y. Cystamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs. Endocrinol. 115:1984;1210-1217.
12. Kapas S., Cammas F.M., Hinson J.P., Clark A.J. Agonist and receptor binding properties of adrenocorticotropin peptides using the cloned mouse adrenocorticotropin receptor expressed in a transfected HeLa cell line. Endocrinol. 137:1996;3291-3294.
13. Kong L.-Y., McMillian M.K., Hudson P.M., Jin L., Hong J.-S. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J. Pharmacol. Exp. Ther. 280:1997;61-66.
14. Loh Y.P., Tam W.W.H., Russell J.T. Measurement of delta pH and membrane potential in secretory vesicles isolated from bovine pituitary intermediate lobe. J. Biol. Chem. 259:1984;8238-8245.
15. Lorenson M.Y., Robson D.L., Jacobs L.S. Divalent cation inhibition of hormone release from isolated adenohypophysial secretory granules. J. Biol. Chem. 258:1983;8618-8622.
16. Lorenson M.Y., Cuccaro M.L., Jacobs L.S. Calcium release from pituitary secretory granules: modulation by thiols, disulfides, and dihydropyridine calcium channel blockers. Endocrinol. 126:1990;2671-2678.
17. Lowry O.N., Rosebrough N.J., Farr A.L., Randall R.-J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
18. Moriarty C.M., Dowd F., Fontaine M. Isolation and characteristics of bovine pituitary secretory granules. Biochim. Biophys. Acta. 761:1983;209-216.
19. Quillan J.M., Sadee W. Dynorphin peptides: antagonists of melanocortin receptors. Pharm. Res. 14(6):1997;713-719.
20. Schioth H.B., Muceniece R., Wikberg J.E. Characterisation of the melanocortin 4 receptor by radioligand binding. Pharmacol. Toxicol. 79:1996;161-165.
21. Shukla V.K., Lemaire S. Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides. J. Psychiatry Neurosci. 17:1992;106-119.
22. Shukla V.K., Lemaire S. Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends Pharmacol. Sci. 15:1994;420-424.
23. Takemori A.E., Loh H.H., Lee N.M. Suppression by dynorphin A-(1-13) of the expression of opiate withdrawal and tolerance in mice. Eur. J. Pharmacol. 221:1992;223-226.
24. 1]dynorphin A peptides of the expression of opiate withdrawal and tolerance in morphine-dependent mice. J. Pharmacol. Exp. Ther. 266:1993;121-124.
25. Tam W.W.H., Andreasson K.I., Loh Y.P. The amino-terminal sequence of pro-opiomelanocortin directs intracellular targeting to the regulated secretory pathway. Eur. J. Cell Biol. 62:1993;294-306.
26. Taylor C.C., Wu D., Soong Y., Yee J.S., Szeto H.H. Differential mechanisms of ovine fetal pituitary stimulation by U50,488H and dynorphin A1-13. Neuroendocrinology. 64:1996;419-424.
27. Taylor C.C., Wu D., Soong Y., Yee J.S., Szeto H.H. K-Opioid agonist, U50,488H, stimulates ovine fetal pituitary-adrenal function via hypothalamic arginine-vasopressin and corticotrophin-releasing factor. J. Pharmacol. Exp. Ther. 277:1996;884-887.
28. Taylor C.C., Wu D., Soong Y., Yee J.S., Szeto H.H. Dynorphin A1-13 stimulates ovine fetal pituitary-adrenal function through a novel nonopioid mechanism. J. Pharmacol. Exp. Ther. 280:1997;416-421.
29. Tulunay F.C., Jen M.F., Chang J.K., Loh H.H., Lee N.M. Possible regulatory role of dynorphin on morphine- and endorphin-dependent analgesia. J. Pharmacol. Exp. Ther. 219:1981;296-298.
30. Walker J.M., Tucker D.E., Coy D.H., Walker D.B., Akil H. Des-tyrosine dynorphin antagonizes morphine analgesia. Eur. J. Pharmacol. 185:1983;121-122.
31. Wen H.L., Ho W.K.K. Suppression of withdrawal symptoms by dynorphin in heroin addicts. Eur. J. Pharmacol. 82:1982;183-186.